Westat has worked with the National Institute on Drug Abuse to help collect data on tobacco usage for around eight years.
Westat has won a potential $809.1 million contract to continue as a main provider of data collection and analysis support to the National Institutes of Health organization focused on combating drug abuse.
The services specifically support the National Institute on Drug Abuse's Population Assessment of Tobacco and Health study known as PATH, which collects data on the impact of tobacco products on population health.
NIDA received two proposals for the potential 13-year contract, the institute said in a Wednesday award notice. Work will take place over an initial five-year base period and up to eight option years.
Westat first won the work in 2016 and is responsible for providing staffing to help NIDA carry out the study as part of its mission to monitor tobacco product use and health outcomes in the U.S.
NIDA has to-date obligated approximately 53% of the current contract's $966 million ceiling, according to GovTribe data. The completion date is listed as November 2028.
In collaboration with NIDA, the Food and Drug Administration uses the PATH Study findings to inform its decisions on the regulation of tobacco products.
The study looks at how and why people start using tobacco and what products they use, how and why people quit, changes in attitudes toward tobacco over time, and differences in attitudes toward tobacco use.